Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance

Molecular Therapy

Volumn 22, Issue 9, 2014, Pages 1678-1687

  Thorne, Amy Haseley ^a   Meisen, Walter H ^a   Russell, Luke ^a   Yoo, Ji Young ^a   Bolyard, Chelsea M ^a   Lathia, Justin D ^b   Rich, Jeremy ^b   Puduvalli, Vinay K ^a   Mao, Hsiaoyin ^a   Yu, Jianhua ^a   Caligiuri, Michael A ^a   Tridandapani, Susheela ^a   Kaur, Balveen ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAMBETA2 INTEGRIN; CYSTEINE RICH PROTEIN 61; INTEGRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; ONCOLYTIC HERPES VIRUS; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY; ONCOLYTIC VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MCP 1 GENE; MCP 3 GENE; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROTEIN BINDING; PROTEIN EXPRESSION; SURVIVAL ANALYSIS; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; ADMINISTRATION AND DOSAGE; ANIMAL; CANCER TRANSPLANTATION; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CHEMOKINE CCL2; CYSTEINE-RICH PROTEIN 61; FEMALE; GENETIC VECTORS; GLIOBLASTOMA; HERPESVIRUS 1, HUMAN; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NEOPLASM TRANSPLANTATION; ONCOLYTIC VIRUSES;

EID: 84964314742     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.101     Document Type: Article

References (38)

1. Stupp, R, Mason, WP, van den Bent, MJ, Weller, M, Fisher, B, Taphoorn, MJ et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
2. Harrow, S, Papanastassiou, V, Harland, J, Mabbs, R, Petty, R, Fraser, M et al. (2004). HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Ther 11: 1648-1658.
3. Markert, JM, Liechty, PG, Wang, W, Gaston, S, Braz, E, Karrasch, M et al. (2009). Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther 17: 199-207.
4. Wojton, J and Kaur, B (2010). Impact of tumor microenvironment on oncolytic viral therapy. Cytokine Growth Factor Rev 21: 127-134.
5. Workenhe, ST and Mossman, KL (2014). Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies. Mol Ther 22: 251-256.
6. Liu, YP, Suksanpaisan, L, Steele, MB, Russell, SJ and Peng, KW (2013). Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy. Sci Rep 3: 2375.
7. Weibel, S, Basse-Luesebrink, TC, Hess, M, Hofmann, E, Seubert, C, Langbein- Laugwitz, J et al. (2013). Imaging of intratumoral inflammation during oncolytic virotherapy of tumors by 19F-magnetic resonance imaging (MRI). PLoS One 8: e56317.
8. Msaouel, P, Opyrchal, M, Domingo Musibay, E and Galanis, E (2013). Oncolytic measles virus strains as novel anticancer agents. Expert Opin Biol Ther 13: 483-502.
9. Athanasopoulos, AN, Schneider, D, Keiper, T, Alt, V, Pendurthi, UR, Liegibel, UM et al. (2007). Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem 282: 26746-26753.
10. Hasan, A, Pokeza, N, Shaw, L, Lee, HS, Lazzaro, D, Chintala, H et al. (2011). The matricellular protein cysteine-rich protein 61 (CCN1/Cyr61) enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic retinopathy. J Biol Chem 286: 9542-9554.
11. Lau, LF (2012). CCN1 and CCN2: blood brothers in angiogenic action. J Cell Commun Signal 6: 121-123.
12. Kurozumi, K, Hardcastle, J, Thakur, R, Shroll, J, Nowicki, M, Otsuki, A et al. (2008). Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61. Mol Ther 16: 1382-1391.
13. Lobel, M, Bauer, S, Meisel, C, Eisenreich, A, Kudernatsch, R, Tank, J et al. (2012). CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci 69: 3101-3113.
14. Bian, Z, Peng, Y, You, Z, Wang, Q, Miao, Q, Liu, Y et al. (2013). CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J Lipid Res 54: 44-54.
15. Moon, HG, Zheng, Y, An, CH, Kim, YK and Jin, Y (2013). CCN1 secretion induced by cigarette smoking extracts augments IL-8 release from bronchial epithelial cells. PLoS One 8: e68199.
16. Koon, HW, Zhao, D, Xu, H, Bowe, C, Moss, A, Moyer, MP et al. (2008). Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis. Am J Pathol 173: 400-410.
17. Bai, T, Chen, CC and Lau, LF (2010). Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J Immunol 184: 3223-3232.
18. Haseley, A, Boone, S, Wojton, J, Yu, L, Yoo, JY, Yu, J et al. (2012). Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Res 72: 1353- 1362.
19. Schober, JM, Chen, N, Grzeszkiewicz, TM, Jovanovic, I, Emeson, EE, Ugarova, TP et al. (2002). Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99: 4457-4465.
20. Schober, JM, Lau, LF, Ugarova, TP and Lam, SC (2003). Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. J Biol Chem 278: 25808-25815.
21. Fulci, G, Breymann, L, Gianni, D, Kurozomi, K, Rhee, SS, Yu, J et al. (2006). Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci USA 103: 12873-12878.
22. Fulci, G, Dmitrieva, N, Gianni, D, Fontana, EJ, Pan, X, Lu, Y et al. (2007). Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. Cancer Res 67: 9398-9406.
23. Hokeness, KL, Kuziel, WA, Biron, CA and Salazar-Mather, TP (2005). Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 174: 1549-1556.
24. Lee, SK, Choi, BK, Kang, WJ, Kim, YH, Park, HY, Kim, KH et al. (2008). MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol Cells 26: 67-73.
25. Lathia, JD, Gallagher, J, Heddleston, JM, Wang, J, Eyler, CE, Macswords, J et al. (2010). Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432.
26. Suganami, T, Nishida, J and Ogawa, Y (2005). A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25: 2062-2068.
27. Parry, GC, Martin, T, Felts, KA and Cobb, RR (1998). IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors. Arterioscler Thromb Vasc Biol 18: 934-940.
28. Brieland, JK, Flory, CM, Jones, ML, Miller, GR, Remick, DG, Warren, JS et al. (1995). Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factoralpha, and interleukin-1 beta. Am J Respir Cell Mol Biol 12: 104-109.
29. Zhou, ZH, Han, Y, Wei, T, Aras, S, Chaturvedi, P, Tyler, S et al. (2001). Regulation of monocyte chemoattractant protein (MCP)-1 transcription by interferon-gamma (IFN-gamma) in human astrocytoma cells: postinduction refractory state of the gene, governed by its upstream elements. FASEB J 15: 383-392.
30. Goodwin, CR, Lal, B, Zhou, X, Ho, S, Xia, S, Taeger, A et al. (2010). Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Res 70: 2932-2941.
31. Young, N, Pearl, DK and Van Brocklyn, JR (2009). Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 7: 23-32.
32. Yu, Y, Gao, Y, Wang, H, Huang, L, Qin, J, Guo, R et al. (2008). The matrix protein CCN1 (CYR61) promotes proliferation, migration and tube formation of endothelial progenitor cells. Exp Cell Res 314: 3198-3208.
33. Kim, B, Sarangi, PP, Lee, Y, Deshpande Kaistha, S, Lee, S and Rouse, BT (2006). Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J Leukoc Biol 80: 1405-1415.
34. Rother, M, Krohn, S, Kania, G, Vanhoutte, D, Eisenreich, A, Wang, X et al. (2010). Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation 122: 2688-2698.
35. Terada, K, Wakimoto, H, Tyminski, E, Chiocca, EA and Saeki, Y (2006). Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Gene Ther 13: 705-714.
36. Wakimoto, H, Fulci, G, Tyminski, E and Chiocca, EA (2004). Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis. Gene Ther 11: 214-223.
37. Yoo, JY, Pradarelli, J, Haseley, A, Wojton, J, Kaka, A, Bratasz, A et al. (2012). Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clin Cancer Res 18: 4931-4941.
38. Huang, P, Rani, MR, Ahluwalia, MS, Bae, E, Prayson, RA, Weil, RJ et al. (2012). Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin 61 in glioblastoma. Cancer Res 72: 1428-1437.